Cystic Fibrosis News Today Daily Digest

Cystic Fibrosis Weekly Update Contents: Alexion Charitable Foundation Giving $1.1M to Assist Rare Disease Community During Pandemic Eloxx Resumes Enrollment in Phase 2 Trial of ELX-02 in Europe, Israel Alexion Charitable Foundation Giving $1.1M to Assist Rare Disease Community During Pandemic Jun 22, 2020 07:15 am | Forest Ray The Alexion Charitable Foundation has awarded $1.1 million in grants to programs that support those with rare diseases during the COVID-19 pandemic, the organization recently announced. The grants will support activities that align with the foundation’s Rare Belonging focus, a set of funding priorities aimed at improving the daily lives of those with rare diseases. […] The post Alexion Charitable Foundation Giving $1.1M to Assist Rare Disease Community During Pandemic appeared first on Cystic Fibrosis News Today. Read More Eloxx Resumes Enrollment in Phase 2 Trial of ELX-02 in Europe, Israel Jun 22, 2020 07:00 am | Vanessa Pataia Eloxx Pharmaceuticals has resumed enrollment in its Phase 2 clinical trial evaluating ELX-02 in cystic fibrosis (CF) patients in Israel and Europe, after it was temporarily halted due to the COVID-19 pandemic.  “We are pleased that enrollment in our Phase 2 clinical trial in cystic fibrosis has been resumed in Israel and Europe, however, our […] The post Eloxx Resumes Enrollment in Phase 2 Trial of ELX-02 in Europe, Israel appeared first on Cystic Fibrosis News Today. Read More   Recent News 4DMT Receives Up to $14M from CFF for Development of Customized Gene Carrier Poll Results Highlight Lack of Awareness About Cystic Fibrosis in the UK Second-hand Smoke Affects Metabolism in Infants and Children with CF, Study Finds Death Is Not a Good Diet Plan Finding Fate in the Fallout